Stocktoria
BALCHEM CORP BCPC
BALCHEM CORP (BCPC) earns a Piotroski F-score of 8/9 (strong financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 0.51% (safety: safe). FY2025 revenue was $1.0B at a 14.9% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.47 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-05-04 | HC Wainwright & Co. | Buy (main) |
| 2026-02-24 | HC Wainwright & Co. | Buy (main) |
| 2025-12-05 | Rothschild & Co | Neutral (init) |
| 2025-10-22 | HC Wainwright & Co. | Buy (main) |
| 2025-08-04 | HC Wainwright & Co. | Buy (main) |
| 2025-04-28 | HC Wainwright & Co. | Buy (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 8/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.112 |
| Retained earnings / assets | 0.665 |
| EBIT / assets | 0.124 |
| Equity / liabilities | 2.932 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| BCPC | BALCHEM CORP | 8/9 | 6.82 | 35.5 | +8.8% |
| NGVT | Ingevity Corp | 6/9 | 2.97 | — | -2.7% |
| IOSP | INNOSPEC INC. | 3/9 | 7.54 | — | -3.7% |
| ACNT | ASCENT INDUSTRIES CO. | 6/9 | 8.71 | 144.9 | -7.2% |
| BLGO | BIOLARGO, INC. | — | — | — | -56.3% |
| GURE | GULF RESOURCES, INC. | 3/9 | — | — | -74.5% |
| LQMT | LIQUIDMETAL TECHNOLOGIES INC | 2/9 | -15.56 | — | — |
About BALCHEM CORP
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
FAQ
Is BCPC financially healthy?
BALCHEM CORP's Piotroski F-score is 8/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does BCPC pay a dividend, and is it safe?
Yes. BALCHEM CORP pays a dividend yielding about 0.51% with a 18.3% payout ratio, rated “safe” for safety.
How profitable is BCPC?
In FY2025, BALCHEM CORP had a net margin of 14.9% and a return on equity of 12.3%.
Is BCPC overvalued or undervalued?
BALCHEM CORP trades at about 37.8× trailing earnings — near its 10-year norm (10-year range 28.3×–50.0×, median 41.2×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for BCPC?
The average Wall-Street price target for BALCHEM CORP is $200.75, about 11.7% above the recent price, from 4 analysts.
Is BCPC a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on BALCHEM CORP: a Piotroski F-score of 8/9, an Altman Z″ in the safe zone, a P/E of about 35.5×, a dividend yield of 0.51%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.